Marrow Mitch
Public Communications Contact en PARADIGM BIOPHARMACEUTICALS LIMITED .
Origen de la red de primer grado Marrow Mitch.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Generic | 12 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Marrow Mitch a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Bonlac Foods Ltd. manufactures dairy products and ingredients for domestic and international customers. The firm products include fresh & UTH milk, milk powders, cheese, spreads, fruit juice, sport drinks, and yoghurts. The company is located in Melbourne, Australia. | Food Distributors | Corporate Officer/Principal | |
| Roche Diagnostics Australia Pty Ltd. | Sales & Marketing | ||
| MERCK KGAA | Pharmaceuticals: Major | Sales & Marketing | |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Biotechnology | Corporate Officer/Principal | |
| IMMURON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| COMPUGEN LTD. | Biotechnology | General Counsel | |
| ALTAIR MINERALS LIMITED | Other Metals/Minerals | Director/Board Member | |
| EVOGENE LTD. | Biotechnology | Director/Board Member | |
| ABIE OILG | Oil & Gas Production | Chairman | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Graduate Degree | |
Synchron, Inc.
 Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | Packaged Software | Chief Operating Officer | |
| The University of Western Australia | College/University | Undergraduate Degree | |
| Muscular Dystrophy Wa | Director/Board Member | ||
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Villanova University | College/University | Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
The Fox Chase Cancer Center
 The Fox Chase Cancer Center Hospital/Nursing ManagementHealth Services The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Director/Board Member | |
National Marrow Donor Program
 National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Part of The Marrow Foundation, National Marrow Donor Program is a company that provides treatments for those facing life-threatening blood cancers. The company is based in Minneapolis, MN. The CEO of the company is Amy L. Ronneberg. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
NewYork-Presbyterian Hospital
 NewYork-Presbyterian Hospital Hospital/Nursing ManagementHealth Services NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| New York State Department of Health | General Government | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| Hahnemann University | College/University | Doctorate Degree | |
| Lewis Katz School of Medicine | College/University | Doctorate Degree | |
| Mailman School of Public Health | College/University | Graduate Degree | |
| SCRIPSAMERICA, INC. | Medical Distributors | Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TZ LIMITED | Computer Communications | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 23 |
| Australia | 15 |
| Israel | 3 |
| Alemania | 2 |
Sectorial
| Health Technology | 15 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Health Services | 4 |
| Distribution Services | 3 |
Operativa
| Corporate Officer/Principal | 17 |
| Director/Board Member | 13 |
| Chief Tech/Sci/R&D Officer | 9 |
| Chief Executive Officer | 4 |
| Undergraduate Degree | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Marrow Mitch
- Conexiones Empresas
